GVB Biopharma’s Post

Trust and transparency are key when sourcing CBD Isolate. Always choose a manufacturer that will provide batch-specific COAs and certification documents. gvbb.io/cbdisolate #cbdisolate #cbdextract #cbdwholesale #hemp

We are hiring in Oregon! Check out the link below for more information. https://lnkd.in/g_jB5RBW

A recent poll by Leafreport gives insight into the minds of CBD users and whether or not their CBD dosage changes based on the time of day. Learn more about how consumers change their CBD dosage based on the time of day in our recent blog. gvbb.io/cbddosage #cbd #dosage #hempsupplier

GVB Biopharma is thrilled to announce its transition back to a private entity controlled by its founding team as of December 28th, 2023. As a privately held company, GVB Biopharma is uniquely positioned to leverage its industry-leading expertise in research, genetics, and proprietary technologies. Read the full press release here: https://lnkd.in/gHx3ggTT

At GVB Biopharma, we strive for excellence. We're committed to hitting industry standards and surpassing them every step of the way.

Sweden's stance on cannabinoids is evolving. Our latest blog sheds light on the present and future of cannabis in the Scandinavian nation. Read our blog to learn more! gvbb.io/swedenlaws

Our vertical integration allows us to have complete control over our cannabinoid production, including our CBD and CBG biomass. Our biomass is the starting material for all of our premium extracts and can be purchased in bulk. gvbb.io/biomass

Terpenes, the aromatic compounds found in a variety of plants and herbs, are not exclusive to hemp. However, they are often associated with cannabis due to its notably high terpene concentrations.

At GVB, our vertical integration allows us to control the process from seed to finished product and ensure our extracts are uncompromising in quality. gvbb.io/about